Chen-Shuan Chung Selected Research

Deglutition Disorders (Dysphagia)

5/2015

Aortic pseudoaneurysm formation following concurrent chemoradiotherapy and metallic stent insertion in a patient with esophageal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chen-Shuan Chung Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 10/2010
7	Hemorrhage 01/2022 - 01/2011
5	Esophageal Neoplasms (Esophageal Cancer) 09/2021 - 06/2010
3	Peptic Ulcer (Peptic Ulcers) 01/2016 - 02/2015
2	Gastroparesis 07/2022 - 05/2019
2	Hepatocellular Carcinoma (Hepatoma) 06/2019 - 10/2010
2	Ulcer 01/2016 - 09/2015
1	Ulcerative Colitis 09/2022
1	Thrombosis (Thrombus) 01/2022
1	Acute Coronary Syndrome 01/2022
1	Short Bowel Syndrome 01/2021
1	Fever (Fevers) 01/2021
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2021
1	Pneumoperitoneum 01/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2018
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 05/2016
1	Esophageal Stenosis (Esophageal Stricture) 05/2016
1	Pathologic Constriction (Stenosis) 05/2016
1	Carcinogenesis 12/2015
1	Fibrosis (Cirrhosis) 05/2015
1	Chronic Hepatitis C 05/2015
1	Deglutition Disorders (Dysphagia) 05/2015
1	False Aneurysm (Pseudoaneurysm) 05/2015
1	Infections 02/2015
1	Protein C Deficiency 01/2015
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2011
1	Leukopenia 10/2010
1	Hypoxia (Hypoxemia) 10/2010
1	Esophageal Squamous Cell Carcinoma 06/2010
1	Bacteremia 12/2008

Drug/Important Bio-Agent (IBA)

2	CarcinogensIBA 01/2022 - 12/2015
2	Proton Pump InhibitorsIBA 01/2016 - 09/2015
2	Alanine Transaminase (SGPT)IBA 05/2015 - 10/2010
1	vedolizumabIBA 09/2022
1	goblet cell silencer inhibitorIBA 07/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 09/2021
1	MetalsIBA 12/2018
1	Biological ProductsIBA 09/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2016
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 07/2016
1	Lansoprazole (Prevacid)FDA LinkGeneric 01/2016
1	AcidsIBA 12/2015
1	Fluorouracil (Carac)FDA LinkGeneric 05/2015
1	Ribavirin (Virazole)FDA LinkGeneric 05/2015
1	RNA (Ribonucleic Acid)IBA 05/2015
1	Cisplatin (Platino)FDA LinkGeneric 05/2015
1	InterferonsIBA 05/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2015
1	UreaseIBA 02/2015
1	AnticoagulantsIBA 01/2015
1	Capsules (Microcapsules)IBA 01/2015
1	Lugol's solution (Lugol's iodine)IBA 10/2013
1	Coloring Agents (Dyes)IBA 01/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2010
1	C-Reactive ProteinIBA 10/2010
1	BilirubinIBA 10/2010

Therapy/Procedure

8	Therapeutics 07/2022 - 01/2011
3	Stents 01/2022 - 05/2015
2	Pyloromyotomy 07/2022 - 05/2019
2	Mechanical Ventilators (Ventilator) 01/2018 - 01/2016
2	Ligation 07/2016 - 01/2011
1	Nutritional Support (Artificial Feeding) 07/2022
1	Myotomy 07/2022
1	Blood Transfusion (Blood Transfusions) 01/2022
1	Transplantation 01/2021
1	Punctures 01/2021
1	Length of Stay 01/2021
1	Liver Transplantation 06/2019
1	Self Expandable Metallic Stents 12/2018
1	Antibiotic Prophylaxis 07/2016
1	Catheters 05/2016
1	Radiofrequency Ablation 05/2016
1	Tertiary Prevention 12/2015
1	Aftercare (After-Treatment) 09/2015
1	Chemoradiotherapy 05/2015
1	Radiotherapy 05/2015
1	Sclerotherapy 01/2011
1	Secondary Prevention 06/2010
1	Nephrotomy 12/2008